Company profile: Health in Code
1.1 - Company Overview
Company description
- Provider of genetic diagnosis and testing services for inherited diseases, with expertise in inherited cardiovascular conditions. Services include full NGS testing from DNA reception to specialized clinical reports, in-house sequencing kits with bioinformatics and variant database, variant interpretation per guidelines, multidisciplinary clinical genetic reports, specialist genetic counseling, and proteomics as a certified Olink Explore service provider.
Products and services
- Variant Interpretation: HIC assesses clinical and molecular findings to determine each genetic variant’s pathogenicity according to international guidelines, delivering guideline-compliant classifications that underpin diagnostic and prognostic decision-making
- Clinical Genetic Report: A multidisciplinary team architects sequencing-derived reports specialized in the genetic diagnosis of inherited diseases, translating results into patient and family context to support diagnostic-to-prognostic care
- Full NGS Genetic Testing Service: HIC executes end-to-end, NGS-based testing entirely in its laboratories—from DNA sample reception through sequencing to specialized clinical reporting—to diagnose inherited cardiovascular diseases comprehensively
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Health in Code
Advanced Cell Diagnostics
HQ: United States
Website
- Description: Provider of molecular pathology cell- and tissue-based diagnostic tests for personalized medicine, including RNAscope for single-molecule, high-specificity RNA detection in intact cells; BaseScope for detecting exon junctions and splice variants in FFPE tissue with morphological context; and miRNAscope for cell-type specific detection of miRNAs, siRNAs, and other small RNAs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Cell Diagnostics company profile →
Krystal Biotech
HQ: United States
Website
- Description: Provider of gene therapies, including FDA-approved VYJUVEK for delivering missing or defective genes to the skin; with focus on Autosomal Recessive Congenital Ichthyosis, Netherton Syndrome, Cystic Fibrosis, and Alpha-1 Antitrypsin Deficiency; and oncology development using a modified HSV-1 vector to deliver IL-12 and IL-2 to the tumor microenvironment for immune-mediated tumor clearance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Krystal Biotech company profile →
Ring Therapeutics
HQ: United States
Website
- Description: Provider of programmable genetic medicines enabled by AnelloScope (anellovirus discovery), AnelloScreen (tissue tropism, redosability, potency, immunogenicity), AnelloDesign (computational vector design), AnelloVector (non-integrating engineered viral nucleic acid delivery), AnelloLP (surface-payload viral particles for immune evasion), and AnelloBricks (scalable manufacturing for clinical and commercial production).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ring Therapeutics company profile →
Seven Bridges
HQ: United States
Website
- Description: Provider of cloud-based infrastructure and data analytics for biomedical research, delivering the Seven Bridges Platform for storing, analyzing and interpreting bioinformatic data; BioInfoMiner for unsupervised genomic interpretation; RHEO for custom automation; GRAF for graph-based NGS variant calling; and ARIA for high-throughput molecular and health data cohort analysis at million-participant scale, with services and support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seven Bridges company profile →
IMGM Laboratories
HQ: Germany
Website
- Description: Provider of advanced genomic services via a service center in Martinsried, Germany for academic and industrial genome research, serving pharma, diagnostics, academia and biotech. Accredited to DIN EN ISO/IEC 17025 for gene expression analysis using Agilent microarrays and qPCR, and offering first-class NGS, metagenomic sequencing, biomarker discovery, pharmacogenetics, and qPCR/ddPCR-based biodistribution studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMGM Laboratories company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Health in Code
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Health in Code
2.2 - Growth funds investing in similar companies to Health in Code
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Health in Code
4.2 - Public trading comparable groups for Health in Code
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →